| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.05 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.52 | 0.06 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.089 | 0.06 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |